White label – Pompe disease - ClinicalTrials.eu

Study on the Effects of Low-Dose Acetylsalicylic Acid in Patients with Bipolar Disorder

Recruiting

2 1 1
Investigated Diseases:
- Bipolar disorder
Investigated Drugs:
- Acetylsalicylic Acid
Study of Atezolizumab with Drug Combination for Patients with Unresectable Metastatic Colorectal Cancer

Recruiting

3 1 1 1
Investigated Diseases:
- Colorectal cancer metastatic
Investigated Drugs:
Comparison of Two Vitamin D3 Doses (500,000 IU vs 750,000 IU) in Critically Ill Patients with Vitamin D Deficiency Receiving Continuous Renal Replacement Therapy

Recruiting

3 1 1 1
Investigated Drugs:
- Colecalciferol
Study on Venous Thromboembolism Prevention with Enoxaparin Sodium and Drug Combination for Patients Undergoing Total Hip or Knee Replacement

Recruiting

3 1 1 1
Investigated Drugs:
Study of leuprorelin and progestogen treatment in women with adenomyosis undergoing assisted reproductive technology to improve pregnancy outcomes

Recruiting

3 1 1 1
Investigated Drugs:
- Leuprorelin Acetate
Study on Managing Heart Failure and Kidney Disease in Elderly Patients with High Potassium Risk Using Sodium Zirconium Cyclosilicate

Recruiting

3 1 1 1
Investigated Diseases:
- Cardiac failure chronic
- Chronic kidney disease
Investigated Drugs:
- Sodium Zirconium Cyclosilicate
Study on Human Fetal Neural Precursor Cells and Tacrolimus for Patients with Progressive Multiple Sclerosis

Recruiting

2 1 1 1
Investigated Diseases:
- Progressive multiple sclerosis
Investigated Drugs:
- Human Neuronal Progenitor/Stem Cells
- Tacrolimus
Study on Sequential Treatment with Gemcitabine, Paclitaxel, and FOLFIRINOX for Patients with Locally Advanced Pancreatic Cancer

Recruiting

2 1 1 1
Investigated Diseases:
- Pancreatic carcinoma
Investigated Drugs:
Study on Filgrastim for Patients with Severe Bullous Drug Eruptions: Lyell and Stevens-Johnson Syndromes

Recruiting

4 1 1
Investigated Diseases:
- Stevens-Johnson syndrome
- Toxic epidermal necrolysis
Investigated Drugs:
- Glucose Monohydrate
- Filgrastim
Study on the Safety and Tolerability of TUB-040 for Patients with Platinum-Resistant Ovarian Cancer or Relapsed/Refractory Non-Small Cell Lung Cancer

Recruiting

2 1 1
Investigated Diseases:
Investigated Drugs:
- Tub-040

Full Name *

e-Mail *

Country Prefix *

Phone Number *

Nationality *

Gender *

Check all consents

Check all consents

I accept the Terms and Conditions and Privacy Policy *

*I accept the Terms and Conditions and Privacy Policy

I consent to receiving commercial information from the Service Operator *

*I consent to receiving commercial information from the Service Operator

I consent to the use of telecommunications terminal equipment and automated calling systems by the Service Operator for marketing communication purposes *

*I consent to the use of telecommunications terminal equipment and automated calling systems by the Service Operator for marketing communication purposes

We use cookies